Atlas Trials

Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Clinical trial NCT00764907 · UNKNOWN

Trial details

NCT number
NCT00764907
Sponsor
University Hospital, Motol
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia
Start date
2002-11-01
Primary completion
2007-10-01
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.